Fundraising Fox
Xylyx Bio
New York, US · 1 known investors
Find your way into Xylyx Bio
Sign up to see every warm intro you have to Xylyx Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Xylyx Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
XYLYX develops transplantation technologies using regenerative medicine, bioengineering, and translational science to expand access to organ transplantation. The company works with surgeons, physicians, and regenerative medicine experts to advance tissue engineering and clinical innovation for transplant applications.
Founders & leadership
JO
John O'NeillChief Scientific Officer, Co-Founder, Board DirectorJohn O'Neill is Chief Scientific Officer and Co-Founder of Xylyx Bio, which develops regenerative medicine and bioengineering technologies for organ transplantation. His background spans translational science, tissue engineering, and work with surgical and regenerative medicine experts on transplant applications.
Investors · 1
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $297.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $224.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $279.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Xylyx Bio do?
- XYLYX develops transplantation technologies using regenerative medicine, bioengineering, and translational science to expand access to organ transplantation. The company works with surgeons, physicians, and regenerative medicine experts to advance tissue engineering and clinical innovation for transplant applications.
- Who founded Xylyx Bio?
- Xylyx Bio was founded by John O'Neill.
- Who are Xylyx Bio's investors?
- Xylyx Bio's investors include Boston Harbor Angels.
- Where is Xylyx Bio headquartered?
- Xylyx Bio is headquartered in New York, US.